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The c-Myc proto-oncogene is an essential activator of cell proliferation and one of the genes most 
commonly deregulated in cancer. Although these activities of c-Myc are thought to result from its 
function as a transcription factor, the scientific literature contains hints that this is not the whole 
story. A new paper in Nature by Dominguez-Sola et al. reports the surprising observation that c-Myc 
promotes DNA replication via a nontranscriptional mechanism, and that c-Myc deregulation causes 
DNA damage predominately during S phase. These results identify c-Myc as a new DNA replication 




Cole,  2006).  Importantly,  there  is 
some  discordance  between  c-Myc 
domains  that  are  required  for  its 
transcriptional activity versus those 
involved in promoting cell prolifera-
tion  and  tumorigenesis.  For  exam-
ple, a deletion of the N-terminal Myc 
Box  I within  its  transcriptional acti-
vation domain is reportedly defective 
for  cellular  transformation  in  vitro 
but  retains  transcriptional  activity 
(Herbst  et  al.,  2005).  These  obser-
vations  have  provoked  suspicions 
that c-Myc may contribute to onco-
genic  transformation  via  nontran-
scriptional activities.
To achieve efficient DNA  replica-
tion,  human  cells  activate  tens  of 
thousands  of  origins  in  each  cell 
cycle. By separating replication ini-
tiation  into  two  steps,  cells  insure 
that  each  origin  undergoes  only 
one initiation event in each S phase 
and  that  the  genome  is  duplicated 
precisely  once  in  each  cell  cycle 
(Arias and Walter, 2007). In the first 
step  (“licensing”),  which  occurs  in 
early  G1,  prereplicative  complexes 
(pre-RCs)  assemble  at  origins  via 
the  sequential  binding  of  the  ori-
gin  recognition  complex  (ORC), 
Cdc6, Cdt1,  and  the MCM2-7  heli-
case (Figure 1). In the second step, 
which occurs at the G1/S transition, 102  Cancer Cell 12, August 2007 ©2007 S  phase-specific  kinases  cooper-
ate  with  numerous  factors  includ-
ing Cdc45  to  activate  the MCM2-7 
helicase,  leading  to  origin  unwind-
ing and replisome assembly. Impor-
tantly,  MCM2-7  vacates  the  origin 
during  initiation,  and  reinitiation  is 
blocked because de novo MCM2-7 
loading  in  S  phase  is  strictly  pro-
hibited due to inhibitors of licensing 
such as Geminin.






pre-RC  components  normally  do 
not associate with each other in the 
absence  of  DNA,  this  result  raises 
the interesting possibility that c-Myc 
might  stabilize  interactions  among 
these factors. Dominguez-Sola et al. 
(2007)  further  show  that c-Myc and 
its  dimerization  partner,  Max,  bind 
within  close proximity of  two highly 
efficient  origins  in  vivo  and  that  it 
colocalizes with DNA replication foci 
early, but not late, in S phase.
In  an  experimental  tour  de  force 
involving cell fusion assays, Domin-
guez-Sola  et  al.  build  a  case  that 
c-Myc’s  regulation  of  DNA  replica-
tion is independent of transcription. 
Thus,  when  a  mouse  cell  arrested 
in G1 is fused with a HeLa cell rich 
in  S  phase-promoting  activities, 
the  mouse  nucleus  within  the  het-Elsevier Inc.erokaryon enters S phase, but only 
if  it  contains  c-Myc.  To  neutralize 
c-Myc-dependent  gene  expres-
sion,  cells  are  fused  in  the  pres-
ence of  cycloheximide,  an  inhibitor 
of  translation.  Although  powerful, 
this experiment cannot exclude the 
possibility  that  DNA  replication  in 
the mouse  nuclei  is  due  to  c-Myc-
dependent  gene  expression  that 
occurred prior to cell fusion.
To rule out transcriptional effects, 
Dominguez-Sola  et  al.  turned  to  a 
cell-free system derived from Xeno-
pus egg extracts (Walter et al., 1998). 




nucleoplasmic  S  phase  extract  that 
promotes  replication  initiation  while 
preventing  reinitiation.  Strikingly, 





there  is  no  transcription  or  protein 
synthesis  in  these  extracts,  this 
result  appears  to  provide  definitive 
evidence that c-Myc promotes DNA 
replication  by  a  nontranscriptional 
mechanism.  Notably,  truncation 
of  the  C-terminal  helix-loop-helix 
domain  prevents  rescue,  suggest-
ing  that  DNA  binding  by  c-Myc  is 
important  for  its  role  in  DNA  repli-
cation. In the future,  it will be inter-
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c-Myc  alleles  that  affect  transfor-
mation  but  not  transactivation  are 
compromised for DNA replication.
The  experiments  in  Xenopus 
egg  extracts  suggest  the  interest-
ing possibility  that c-Myc defines a 
novel G1-specific step in replication 
initiation  (Figure  1).  Thus,  c-Myc 
must be supplied by the G1 extract, 
since  the presence of c-Myc  in  the 
S phase  extract  is  not  sufficient  to 
promote DNA replication. Paradoxi-
cally,  however,  the  major  replica-




replication  step  in  G1  that  is  inde-
pendent  of  pre-RC  formation  and 
that  precedes  origin  activation  in 
S phase. An  interesting question  is 
why c-Myc cannot exert its function 
in  S  phase.  Perhaps  there  exist  S 
phase-specific  factors  that  inhibit 
the  replication  activity  of  c-Myc, 
analogous to the S phase inhibition 
of  pre-RC  formation  by  Geminin. 
Based  on  these  considerations,  c-
Myc could represent a novel licens-
ing  factor.  It  will  be  important  to 




To  explore  potential  mechanisms 
of  c-Myc-induced  tumorigenesis, 
Dominguez-Sola  et  al.  examined 
the  effects  of  c-Myc overexpression 
on DNA  replication.  In Xenopus  egg 
extracts  and  in  tissue  culture  cells, 
excess  c-Myc  stimulates  DNA  repli-
cation  above  normal  levels.  In  cells, 
this  is manifested  as  an  increase  in 
replication foci, and in extracts, as an 
enhanced  initial  rate of DNA replica-





elevated  rate  of  DNA  replication  in 
early S phase, DNA replication does 
not go to completion in egg extracts. 
This  result  suggested  that  the 
enhanced firing of early origins might 
cause  DNA  damage  and  a  check-




break  formation,  and  that  complete 
DNA  replication  is  restored  by  inhi-
bition  of  checkpoint  kinases.  Based 





It  now  appears  there  are  several 
different mechanisms by which inap-
propriate origin usage can give  rise 
to  genomic  instability  and  cancer. 
figure 1. Mechanism of Replication 
Initiation and Putative Role of Myc in 
This Process
Origins are licensed in early G1 phase via the 
ORC-dependent  assembly  of  prereplication 
complexes  on  DNA.  At  the  G1/S  transition, 
protein  kinases  promote  replication  initiation 
by  stimulating  Cdc45-  and  MCM2-7-depen-
dent origin unwinding. Myc appears to act af-





and  Schwob,  2002;  Shima  et  al., 
2007;  Tanaka  and  Diffley,  2002). 
Second,  when  the  same  origins 
are  used  repeatedly  in  the  same  S 
phase  due  to  unrestrained  licens-
ing, overreplication results, and this 
is a possible cause of DNA damage 
and  tumorigenesis  (Davidson  et  al., 
2006; Seo et al., 2005). Dominguez-
Sola  et  al.  add  a  third  variation  on 
this  theme.  Their  results  demon-
strate  that  enhanced  origin  usage 
early  in S phase causes DNA dam-
age  even  in  the  absence  of  rerepli-




to  replication  fork  collapse.  If  cor-
rect,  this model would  explain why, 
in most organisms, only a fraction of 







Davidson,  I.F.,  Li,  A.,  and  Blow,  J.J.  (2006). 
Mol. Cell 24, 433–443.
Dominguez-Sola,  D.,  Ying,  C.Y.,  Grandori, 




Herbst,  A.,  Hemann, M.T.,  Tworkowski,  K.A., 
Salghetti, S.E., Lowe, S.W., and Tansey, W.P. 
(2005). EMBO Rep. 6, 177–183.
Lengronne,  A.,  and  Schwob,  E.  (2002).  Mol. 
Cell 9, 1067–1078.




Andrews,  C.A.,  Munroe,  R.J.,  Hartford,  S.A., 




Walter,  J.,  Sun,  L.,  and  Newport,  J.  (1998). 
Mol. Cell 1, 519–529., August 2007 ©2007 Elsevier Inc.  103
